It is a common perception that approximately 50% of heart failure (HF) patients present with a normal or near-normal left ventricular (LV) ejection fraction ("HF with preserved systolic function"), ...
Verywell Health on MSN
Types of heart failure and how they affect you
Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Heart failure happens when the heart can't pump enough blood ...
The heart is a muscle like no other, beating 60 to 100 times per minute on average, around the clock. But when it grows weak, it can lead to serious problems: from debilitating shortness of breath and ...
Other medical therapy options. The use of digoxin has not been shown to improve survival rates. 10 In the presence of atrial fibrillation, digoxin can be added after the beta-blocker dose has been ...
Nonpharmacologic heart failure management and interventions can reduce cardiovascular risk factors and carotid intima-media ...
The Phase 2b SEISMiC Extension Study showed istaroxime significantly improved systolic blood pressure over six hours compared to placebo. Windtree plans to present detailed study findings, including ...
Research from Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital and Massachusetts General Hospital suggests tai chi exercise may improve the quality of life for patients with systolic ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
Why has a 64-year-old man become increasingly short of breath over the past 2 weeks? That's what Sandra K. Rabat, DO, of A.T. Still University School of Osteopathic Medicine in Mesa, Arizona, and ...
Heart failure is a major health issue associated with mortality and high healthcare costs. Overall heart failure prevalence is growing around the world, currently affecting 1% to 3% of the population.
The second agent is ivabradine, which works by selectively inhibiting the funny channel current of the sinoatrial node. The recommended indication is to reduce hospitalization for HF in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results